RBC Capital Maintains Outperform on Pharvaris, Raises Price Target to $52

Pharvaris N.V.

Pharvaris N.V.

PHVS

0.00

RBC Capital analyst Brian Abrahams maintains Pharvaris (NASDAQ: PHVS) with a Outperform and raises the price target from $51 to $52.